NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


Don't have an account? Subscribe

ADVERTISEMENT

ADVERTISEMENT

Reimbursement begins for new blood glucose monitoring system

By Mindo - 03rd May 2018

In a recent circular to pharmacists, the HSE outlined that the blood glucose management system has been approved from 1 April.

“The FreeStyle Libre flash glucose monitoring system is intended to be used as an alternative to current glucose monitoring methods for people who administer multiple daily injections of insulin,” Ms Anne Marie Hoey, Assistant National Director, Primary Care Reimbursement and Eligibility, explained in the circular.

“Due to the budget impact associated with this medicine, PCRS is introducing a reimbursement application system. This will be confined to children and young adults who require multiple dose injections of insulin in the first instance, with a review after 12 months. The reimbursement application can be made by the consultant endocrinologist responsible for the initiation of treatment through the PCRS hospital application suite.”

The circular also notes that each sensor is being reimbursed at a cost of €55.35 and that reimbursement is available for 26 sensors per patient per year, which equates to a cost per patient per year of almost €1,500.

In January, Minister for Health Simon Harris announced that approval had been granted for the sensor after the HSE’s Health Technology Assessment Group recommended that reimbursement should be considered for certain conditions.

“This innovative device will allow blood glucose levels to be monitored without invasive finger prick testing, which will be very welcome news for both parents and children.  I know that some patients have to test their glucose levels up to 10 times a day and I hope that inconvenience and discomfort can be minimised for as many children and young adults as possible,” Minister Harris remarked in January.

Leave a Reply

ADVERTISEMENT

Latest

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

ADVERTISEMENT

Most Read

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT